Package 68462-404-67

{"route": ["ORAL"], "spl_id": "35216261-40cc-4bcc-b2ce-4d027e1d7b71", "openfda": {"nui": ["N0000175482", "N0000175485"], "upc": ["0368462402016", "0368462404010"], "unii": ["Y883P1Z2LT", "R71Y86M0WT"], "rxcui": ["864675", "864681"], "spl_set_id": ["4b80d087-eaa7-448f-967e-344de7f16436"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc.,USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (68462-404-01)", "package_ndc": "68462-404-01", "marketing_start_date": "20110915"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (68462-404-67)  / 12 TABLET, FILM COATED in 1 BLISTER PACK (68462-404-44)", "package_ndc": "68462-404-67", "marketing_start_date": "20110915"}], "brand_name": "Atovaquone and Proguanil Hydrochloride", "product_id": "68462-404_35216261-40cc-4bcc-b2ce-4d027e1d7b71", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Antimalarial [EPC]", "Antimalarial [EPC]", "Antiprotozoal [EPC]", "Dihydrofolate Reductase Inhibitors [MoA]"], "product_ndc": "68462-404", "generic_name": "Atovaquone and Proguanil Hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc.,USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone and Proguanil Hydrochloride", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "250 mg/1"}, {"name": "PROGUANIL HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA091211", "marketing_category": "ANDA", "marketing_start_date": "20110915", "listing_expiration_date": "20271231"}